BSE Live
Jan 30, 15:01Prev. Close
424.65
Open Price
424.65
Bid Price (Qty.)
420.70 (11)
Offer Price (Qty.)
421.80 (35)
NSE Live
Jan 30, 15:01Prev. Close
424.55
Open Price
420.00
Bid Price (Qty.)
421.10 (30)
Offer Price (Qty.)
421.45 (1)
| Cash Flow of Thyrocare Technologies (in Rs. Cr.) | Mar 15 | |
| 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 67.62 | |
| Net CashFlow From Operating Activities | 34.46 | |
| Net Cash Used In Investing Activities | -17.97 | |
| Net Cash Used From Financing Activities | -22.84 | |
| Foreign Exchange Gains / Losses | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -6.35 | |
| Cash And Cash Equivalents Begin of Year | 11.42 | |
| Cash And Cash Equivalents End Of Year | 5.08 |
29.01.2026
Thyrocare Techn Consolidated December 2025 Net Sales at Rs 195.53 crore, up 17.85% Y-o-Y
29.01.2026
Thyrocare Techn Standalone December 2025 Net Sales at Rs 182.48 crore, up 19.62% Y-o-Y
29.01.2026
28.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
29.01.2026
Thyrocare Techn Consolidated December 2025 Net Sales at Rs 195.53 crore, up 17.85% Y-o-Y
29.01.2026
Thyrocare Techn Standalone December 2025 Net Sales at Rs 182.48 crore, up 19.62% Y-o-Y
28.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
15.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
06.10.2021
Thyrocare Technologies Q2 PAT may dip 2.9% YoY to Rs 41.8 cr: Prabhudas Lilladher
12.07.2019
Thyrocare Technologies Q1 PAT may dip 6.5% YoY to Rs. 22.1 cr: Prabhudas Lilladher
12.04.2019
Thyrocare Technologies Q4 PAT seen up 18.1% YoY to Rs. 29.7 cr: Prabhudas Lilladher
17.04.2018
Thyrocare Technologies Q4 PAT seen up 68.7% YoY to Rs 32 cr: Edelweiss